Levocarnitine propionate hydrochloride

盐酸丙酰左卡尼汀

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameLevocarnitine propionate hydrochloride
Drug Alias NameL-Propionylcarnitine hydrocloridel氯化丙酰左卡尼汀Propionyl-L-carnitine hydrochloridePropionyl-L-carnitine HClDromos +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPyruvate dehydrogenase kinase stimulants
TargetsPyruvate dehydrogenase kinase
Therapy Area/IndicationsPeripheral Vascular DiseasesIntermittent ClaudicationPeripheral Arterial Disease +[5] 
Global Approved IndicationsPeripheral Vascular DiseasesHeart Failure
Approved Indications in ChinaN/A
Original Approved Country/TerritoryItaly
Original Approved Date1998/01/01
Country/TerritoryUnited StatesPolandItaly +[11] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPending
Originator CompaniesSigma-Tau Spa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLee'S Pharmaceutical LtdSigma-Tau Research IncSigma-Tau Ifr Spa +[5] 
Active IndicationsPeripheral Vascular DiseasesHeart Failure
Inactive IndicationsIntermittent ClaudicationPeripheral Arterial DiseaseColitis, Ulcerative

Other Information

ATC CodeA16AA01
Related LinksN/A